These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4348776)

  • 1. Suppression of pituitary tumor growth and function by ergot alkaloids.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):849-55. PubMed ID: 4348776
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo effect of sex hormones on the in vitro synthesis of prolactin and growth hormone in normal and pituitary tumor-bearing rats.
    MacLeod RM; Abad A; Eidson LH
    Endocrinology; 1969 Jun; 84(6):1475-83. PubMed ID: 4305502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphology and function of pituitary cells].
    Ishikawa H
    Naika; 1971; 28(1):17-29. PubMed ID: 4327700
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of four transplantable mammotropic pituitary tumor variants in the rat.
    Ueda G; Takizawa S; Moy P; Marolla F; Furth J
    Cancer Res; 1968 Oct; 28(10):1963-75. PubMed ID: 4301458
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ultrastructural study of anterior pituitary secretion].
    Pelletier G
    Union Med Can; 1973 Mar; 102(3):546-50. PubMed ID: 4351569
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenocortical structure and function in rats bearing an adrenocorticotrophic hormone, growth hormone, and prolactin-secreting tumor.
    Nickerson PA; Brownie AC; Molteni A
    Lab Invest; 1970 Oct; 23(4):368-77. PubMed ID: 4360549
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of pituitary gland hormone content by pituitary tumor hormones.
    MacLeod RM; DeWitt GW; Smith MC
    Endocrinology; 1968 May; 82(5):889-94. PubMed ID: 4297459
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine function after external pituitary irradiation in patients with secreting and nonsecreting pituitary tumours.
    Jenkins JS; Ash S; Bloom HJ
    Q J Med; 1972 Jan; 41(161):57-69. PubMed ID: 4116045
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary hormones and ergot alkaloids.
    Müller EE; Cocchi D; Panerai AE; Gil-Ad I; Locatelli V; Mantegazza P
    Pharmacology; 1978; 16 Suppl 1():63-77. PubMed ID: 205891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hormone-secretin pituitary tumors on RNA biosynthesis in rat anterior pituitary.
    MacLeod RM; Lehmeyer JE
    J Natl Cancer Inst; 1974 Mar; 52(3):823-8. PubMed ID: 4826565
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1974 Feb; 34(2):345-50. PubMed ID: 4810907
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors.
    Lamberts SW
    Endocr Rev; 1988 Nov; 9(4):417-36. PubMed ID: 2905987
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of colchicine and 2-Br-alpha-ergocryptine-methane-sulfonate (CB 154) on the release of prolactin and growth hormone by functional pituitary tumor cells in culture.
    Gautvik KM; Hoyt RF; Tashjian AH
    J Cell Physiol; 1973 Dec; 82(3):401-9. PubMed ID: 4204326
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ergocornine on transplanted mammary tumor growth and pituitary prolactin level in BALB/c mice.
    Singh DV; Meites J; Halmi L; Kortright KH; Brennan MJ
    J Natl Cancer Inst; 1972 Jun; 48(6):1727-31. PubMed ID: 5056256
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary mammotropic tumor in rats: evidence for a dosage effect on organ weight and liver drug metabolism.
    Wilson JT
    J Natl Cancer Inst; 1969 Nov; 43(5):1067-72. PubMed ID: 4311050
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory aids in the diagnosis of pituitary tumors.
    Kolodny HD; Sherman L
    Ann Clin Lab Sci; 1974; 4(2):67-86. PubMed ID: 4362220
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
    Vigneri R; Goldfine ID
    Adv Intern Med; 1980; 25():69-89. PubMed ID: 6102431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.